Jingyan Li

1.4k total citations
52 papers, 969 citations indexed

About

Jingyan Li is a scholar working on Molecular Biology, Epidemiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Jingyan Li has authored 52 papers receiving a total of 969 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 10 papers in Epidemiology and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Jingyan Li's work include Sirtuins and Resveratrol in Medicine (4 papers), Signaling Pathways in Disease (4 papers) and Microbial Natural Products and Biosynthesis (3 papers). Jingyan Li is often cited by papers focused on Sirtuins and Resveratrol in Medicine (4 papers), Signaling Pathways in Disease (4 papers) and Microbial Natural Products and Biosynthesis (3 papers). Jingyan Li collaborates with scholars based in China, United States and Hong Kong. Jingyan Li's co-authors include Cristina M. Sabliov, Yingping Tian, Yong-ming Yao, Panxia Wang, Jing Lü, Peiqing Liu, Zhen Guo, Junjian Wang, Zhenzhen Li and Zhuoming Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

In The Last Decade

Jingyan Li

51 papers receiving 955 citations

Peers

Countries citing papers authored by Jingyan Li

Since Specialization

Citations

This map shows the geographic impact of Jingyan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingyan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingyan Li more than expected).

Fields of papers citing papers by Jingyan Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingyan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingyan Li. The network helps show where Jingyan Li may publish in the future.

Co-authorship network of co-authors of Jingyan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Jingyan Li. A scholar is included among the top collaborators of Jingyan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingyan Li. Jingyan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Screening Methods for Cervical Cancer 2024 ·ChemMedChem ·Jingyan Li, (unknown), (unknown), (unknown), (unknown), (unknown), Li Gao	3
2	Sex differences in CXCL4‐mediated lung damage in the bleomycin‐induced systemic sclerosis mice model 2024 ·SHILAP Revista de lepidopterología ·(unknown), Jingyan Li, (unknown), Yu Chen, (unknown), Yuhong Li	1
3	Cryptotanshinone affects HFL-1 cells proliferation by inhibiting cytokines secretion in RAW264.7 cells and ameliorates inflammation and fibrosis in newborn rats with hyperoxia induced lung injury 2023 ·Frontiers in Pharmacology ·(unknown), (unknown), Jingyan Li, (unknown), (unknown), Jingjing Hu, (unknown), Zhaofang Tian	2
4	Establishment of a juvenile mouse asthma model induced by postnatal hyperoxia exposure combined with early OVA sensitization 2023 ·Heliyon ·Jingyan Li, (unknown), (unknown), Mengmeng Ma, (unknown), Yuan Zhang, Rong Wu, Haiyan Zhu, (unknown)	1
5	Effects of early postnatal hyperoxia exposure combined with early ovalbumin sensitization on lung inflammation and bacterial flora in a juvenile mouse model of asthma 2023 ·Frontiers in Microbiology ·Jingyan Li, (unknown), (unknown), Mengmeng Ma, Yuan Zhang, Zhaofang Tian	2
6	Zinc Oxide Nanoparticles Induce Renal Injury by Initiating Oxidative Stress, Mitochondrial Damage and Apoptosis in Renal Tubular Epithelial Cells 2023 ·Biological Trace Element Research ·Shuang Liu, (unknown), Yaran Shi, (unknown), Xinyu Wang, Jingyan Li, Bin Liao, Ji-Min Cao, Guang Li	8
7	Comparative Analysis of the Metabolites and Biological Activity of Cultivated and Wild Lignosus rhinocerotis 2022 ·BioMed Research International ·(unknown), (unknown), (unknown), (unknown), (unknown), Jingyan Li, Ruoting Zhan, (unknown), Li Liu, (unknown), (unknown)	2
8	Dose-Sparing Intradermal DTaP-sIPV Immunization With a Hollow Microneedle Leads to Superior Immune Responses 2021 ·Frontiers in Microbiology ·(unknown), Jingyan Li, Wenwen Jiang, (unknown), Yan Ma, Qin Gu, Xiaoyu Wang, (unknown), Li Shi, Mingbo Sun	11
9	A two-adjuvant multiantigen candidate vaccine induces superior protective immune responses against SARS-CoV-2 challenge 2021 ·Cell Reports ·Wenwen Jiang, Li Shi, (unknown), Xiaoyu Wang, Jingyan Li, (unknown), (unknown), Qin Gu, Guang Ji, Jing Li, Longding Liu, Mingbo Sun	23
10	The cross-talk between PARylation and SUMOylation in C/EBPβ at K134 site participates in pathological cardiac hypertrophy 2021 ·International Journal of Biological Sciences ·Luping Wang, Panxia Wang, Suowen Xu, Zhuoming Li, Dayue Darrel Duan, Jiantao Ye, Jingyan Li, Yan-qing Ding, Wenqing Zhang, Jing Lü, Peiqing Liu	8
11	A Novel Insight Into the Fate of Cardiomyocytes in Ischemia-Reperfusion Injury: From Iron Metabolism to Ferroptosis 2021 ·Frontiers in Cell and Developmental Biology ·Jingyan Li, Shuangqing Liu, Ren-qi Yao, Yingping Tian, Yongming Yao	46
12	Ferroptosis: A Trigger of Proinflammatory State Progression to Immunogenicity in Necroinflammatory Disease 2021 ·Frontiers in Immunology ·Jingyan Li, Yong-ming Yao, Yingping Tian	62
13	The poly(ADP-ribosyl)ation of BRD4 mediated by PARP1 promoted pathological cardiac hypertrophy 2020 ·Acta Pharmaceutica Sinica B ·Zhenzhen Li, Zhen Guo, Rui Lan, (unknown), Zhirong Lin, Jingyan Li, Junjian Wang, (unknown), (unknown), Peiqing Liu	27
14	MicroRNA-214 contributes to Ang II-induced cardiac hypertrophy by targeting SIRT3 to provoke mitochondrial malfunction 2020 ·Acta Pharmacologica Sinica ·Yan-qing Ding, Yuhong Zhang, Jing Lü, Li Bai, Wenjing Yu, Zhongbao Yue, Yuehuai Hu, Panxia Wang, Jingyan Li, (unknown), Jiantao Ye, Peiqing Liu	35
15	SIRT6 Suppresses NFATc4 Expression and Activation in Cardiomyocyte Hypertrophy 2019 ·Frontiers in Pharmacology ·Zhenzhen Li, (unknown), Xiaoying Zhang, Zhen Guo, Zhong Yao, Panxia Wang, Jingyan Li, Zhuoming Li, Peiqing Liu	31
16	Sex Differences in the Prevalence, Awareness, Treatment, and Control of Diabetes Mellitus Among Adults Aged 45 Years and Older in Rural Areas of Northern China: A Cross-Sectional, Population-Based Study 2019 ·Frontiers in Endocrinology ·Jingyan Li, Jingxian Ni, Yanan Wu, Hongyan Zhang, Jie Liu, Jun Tu, Jingqiu Cui, Xianjia Ning, Jinghua Wang	22
17	Immune Evasion of Enteroviruses Under Innate Immune Monitoring 2018 ·Frontiers in Microbiology ·Ying Zhang, Jingyan Li, Qihan Li	17
18	Clinical and genetic characteristics of Chinese patients with familial or sporadic pediatric cataract 2018 ·Orphanet Journal of Rare Diseases ·Jingyan Li, (unknown), (unknown), Lulu Yan, Chaoxia Lu, Yang Luo, Xue Zhang, Lihua Cao	45
19	SIRT6 suppresses phenylephrine-induced cardiomyocyte hypertrophy though inhibiting p300 2016 ·Journal of Pharmacological Sciences ·(unknown), Xiaojun Feng, Xiaoying Zhang, Xiaoyang Huang, (unknown), (unknown), Jingyan Li, Jia You, Jing Lü, Zhuoming Li, Jiantao Ye, Peiqing Liu	40
20	On-line identification of 4″-isovalerylspiramycin I in the genetic engineered strain of S. spiramyceticus F21 by liquid chromatography with electrospray ionization tandem mass spectrometry, ultraviolet absorbance detection and nuclear magnetic resonance spectrometry 2010 ·Journal of Chromatography A ·Jingyan Li, Chunyan Ma, Hongyuan Wang, Yinghong Wang, (unknown), (unknown), Yiguang Wang	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact